Page last updated: 2024-12-08

bactenecin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bactenecin: from bovine neutrophils [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID163998
MeSH IDM0158335

Synonyms (5)

Synonym
arg-leu-cyclo(cys-arg-ile-val-val-ile-arg-val-cys)-arg
bactenecin
bac7
2-[[28-[[2-[[2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoyl]amino]-13,22-di(butan-2-yl)-10,25-bis[3-(diaminomethylideneamino)propyl]-6,9,12,15,18,21,24,27-octaoxo-7,16,19-tri(propan-2-yl)-1,2-dithia-5,8,11,14,17,20,23,26-octazacyclo
PD150815

Research Excerpts

Overview

Bactenecin (Bac) is a 12-residue disulfide-linked antimicrobial peptide. It is isolated from the granules of bovine neutrophils.

ExcerptReferenceRelevance
"The bactenecin is an antibacterial peptide with an intramolecular disulfide bond. "( Different modes of antibiotic action of homodimeric and monomeric bactenecin, a cathelicidin-derived antibacterial peptide.
Jung, HH; Kim, HJ; Kim, JI; Lee, JY; Lee, SK; Shin, SY; Yang, ST, 2009
)
1.15
"Bactenecin (Bac) is a 12-residue disulfide-linked antimicrobial peptide isolated from the granules of bovine neutrophils. "( Linear bactenecin analogs with cell selectivity and anti-endotoxic activity.
Hai Nan, Y; Jacob, B; Kim, Y; Yub Shin, S, 2012
)
2.28
"Bactenecin 5 (Bac 5) is an antibacterial 43mer peptide isolated from bovine neutrophils. "( Antibacterial activity of bactenecin 5 fragments and their interaction with phospholipid membranes.
Aoyagi, H; Hatakeyama, T; Niidome, T; Tokunaga, Y, 2001
)
2.05
"Bactenecins are a class of arginine-rich antibacterial peptides of bovine neutrophil granules. "( Rapid membrane permeabilization and inhibition of vital functions of gram-negative bacteria by bactenecins.
Gennaro, R; Romeo, D; Skerlavaj, B, 1990
)
1.94
"Bactenecin is an antimicrobial peptide isolated from bovine neutrophils. "( Antimicrobial activity of synthetic bactenecin.
Cerretti, DP; Gallis, B; March, CJ; Martin, JA; Mehl, J; Merriam, J; Prickett, KS,
)
1.85

Dosage Studied

ExcerptRelevanceReference
"Local delivery of anti-HIV drugs to the colorectal mucosa, a major site of HIV replication, and their retention within mucosal tissue would allow for a reduction in dose administered, reduced dosing frequency and minimal systemic exposure."( Colorectal delivery and retention of PEG-Amprenavir-Bac7 nanoconjugates--proof of concept for HIV mucosal pre-exposure prophylaxis.
Ganapathi, U; Gunaseelan, S; Myers, DR; Nelson, AG; Palombo, MS; Samizadeh, M; Singh, Y; Sinko, PJ; Szekely, Z; Zhang, X, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (76)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (2.63)18.7374
1990's23 (30.26)18.2507
2000's21 (27.63)29.6817
2010's29 (38.16)24.3611
2020's1 (1.32)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.85

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.85 (24.57)
Research Supply Index4.37 (2.92)
Research Growth Index5.57 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.85)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (5.13%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other74 (94.87%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]